We are live on ! Find out more
ELAN icon

Elanco Animal Health

440 hedge funds and large institutions have $14.1B invested in Elanco Animal Health in 2020 Q4 according to their latest regulatory filings, with 112 funds opening new positions, 165 increasing their positions, 100 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

273% more first-time investments, than exits

New positions opened: 112 | Existing positions closed: 30

65% more repeat investments, than reductions

Existing positions increased: 165 | Existing positions reduced: 100

38% more funds holding in top 10

Funds holding in top 10: 811 (+3)

22% more capital invested

Capital invested by funds: $11.5B → $14.1B (+$2.57B)

22% more funds holding

Funds holding: 360440 (+80)

9.5% more ownership

Funds ownership: 87.65%97.15% (+9.5%)

36% less call options, than puts

Call options by funds: $46.7M | Put options by funds: $73.1M

Holders
440
Holders Change
+80
Holders Change %
+22.22%
% of All Funds
7.79%
Holding in Top 10
11
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+37.5%
% of All Funds
0.19%
New
112
Increased
165
Reduced
100
Closed
30
Calls
$46.7M
Puts
$73.1M
Net Calls
-$26.4M
Net Calls Change
+$22.4M
Name Holding Trade Value Shares
Change
Change in
Stake
CAAS
301
Capital Asset Advisory Services
Michigan
$379K +$133K +4,364 +55%
CAM
302
Cypress Asset Management
Texas
$377K +$82.6K +2,707 +28%
CFB
303
Cullen/Frost Bankers
Texas
$376K -$323K -10,593 -46%
Russell Investments Group
304
Russell Investments Group
United Kingdom
$368K -$54K -1,771 -13%
JC
305
Jacobs & Co
California
$352K -$28.8K -943 -8%
WCM
306
Washington Capital Management
Washington
$350K
GC
307
Guggenheim Capital
Illinois
$345K -$66.7K -2,187 -16%
RJFSA
308
Raymond James Financial Services Advisors
Florida
$345K +$98.9K +3,243 +41%
SM
309
Sciencast Management
New Jersey
$341K +$331K +10,839 New
MML Investors Services
310
MML Investors Services
Massachusetts
$332K +$87.3K +2,862 +36%
WG
311
Winton Group
United Kingdom
$330K +$328K +10,753 New
Cetera Investment Advisers
312
Cetera Investment Advisers
Illinois
$324K +$323K +10,582 New
CWM
313
Circle Wealth Management
New Jersey
$321K
HC
314
Henshaw Capital
Massachusetts
$317K +$27.5K +900 +10%
MC
315
Maverick Capital
Texas
$314K +$312K +10,240 New
LFAS
316
Level Four Advisory Services
Texas
$313K
OGC
317
One68 Global Capital
New York
$307K +$305K +10,000 New
BAM
318
Belpointe Asset Management
Nevada
$305K +$4.94K +162 +2%
RCA
319
Resonant Capital Advisors
Wisconsin
$302K +$12.9K +422 +4%
BCV
320
Banque Cantonale Vaudoise
Switzerland
$294K -$79.3K -2,600 -21%
TCM
321
Tran Capital Management
California
$286K
NSEDCP
322
NJ State Employees Deferred Compensation Plan
New Jersey
$282K
MLICM
323
Metropolitan Life Insurance Company (MetLife)
New York
$271K +$25.1K +822 +10%
ProShare Advisors
324
ProShare Advisors
Maryland
$261K +$260K +8,521 New
SP
325
Symmetry Partners
Connecticut
$260K -$88.9K -2,915 -26%

ELAN Hedge Fund Activity: Q4 2020 in Review

440 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q4 2020, worth a combined $14.1B — up 22% from $11.5B a quarter earlier.

Buyers outnumbered sellers: 112 funds opened new ELAN positions and 30 closed out — a net gain of 82 holders — while 165 added to existing stakes and 100 trimmed.

The largest buyer was Sachem Head Capital Management, adding an estimated $743M. The largest seller was UBS Group, cutting an estimated $368M.

  • 440 institutional investors held Elanco Animal Health (ELAN) as of Q4 2020, up from 360 in Q3 2020.
  • Funds reported $14.1B of Elanco Animal Health stock for Q4 2020, up 22% quarter-over-quarter.
  • 112 funds opened new Elanco Animal Health positions in Q4 2020 and 30 closed out, a net change of +82 holders.
  • The largest Elanco Animal Health buyer in Q4 2020 was Sachem Head Capital Management, an estimated $743M added.
  • The largest Elanco Animal Health seller in Q4 2020 was UBS Group, an estimated $368M sold.

Based on aggregated 13F filings for Q4 2020.